TABLE 8.
Sl. No. | Title | NCT No. | Therapeutic Dose | Phase | Location |
---|---|---|---|---|---|
1 | Estimating adipose-derived MSCs based therapy | NCT04341610 | Dilution of cells in saline (1:1) | 1,2 | Denmark |
2 | Estimating efficacy of bone Marrow-Derived MSCs therapy | NCT04346368 | 1*10E6/kg body weight | 1,2 | China |
3 | Estimation of the use of human MSCs | NCT04339660 | 1*10E6 Uc-MSCs/kg body weight after suspending in saline (100 ml) | 1,2 | China |
4 | Evaluation of Uc-MSCs therapy | NCT04333368 | 1 Million/kg body weight | 1,2 | France |
5 | Evaluation of Allogeneic based MSCs safety via Clinical trials | NCT04348435 | 200 million cells as a single dose | 2 | U.S. |